511MO A phase I study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, in patients with advanced non-small cell lung cancer (NSCLC)

Authors:
  • JFJ. Feng
    J. Feng
  • MSM. Shi
    M. Shi
  • JCJ. Chen
    J. Chen
  • KLK. Li
    K. Li
  • XLX. Li
    X. Li
  • MSM. Sun
    M. Sun
  • BLB. Li
    B. Li
  • GWG. Wen
    G. Wen
  • YFY. Fang
    Y. Fang
  • XMX. Min
    X. Min
  • LLL. Lin
    L. Lin
  • YLY. Liu
    Y. Liu

Abstract
No abstract available